MedPath

Effects of Intranasal Oxytocin on Functional Brain Network in Resting-state and Tasks

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Placebo
Registration Number
NCT03428906
Lead Sponsor
Beijing Normal University
Brief Summary

To investigate whether and how intranasal oxytocin of 8IU treatment will alter the topology of functional brain network in resting-state and multiple tasks in healthy males.

Detailed Description

In a randomized, double-blind, cross-over, placebo controlled design, healthy male volunteers receive intranasal oxytocin or placebo prior to functional magnetic resonance imaging.Subjects will then go through a decision making task, a emotion judgement task and an eight-minute resting-state scan in MRI scanner to investigate whether and how intranasal oxytocin alter the topology of functional brain network in resting-state and multiple tasks in healthy males. State anxiety and mood are measured before and after experiment as covariates to be controlled.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
34
Inclusion Criteria
  • healthy subjects without past or current psychiatric or neurological disorders
Exclusion Criteria
  • with MRI Contraindications

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboPlacebo contains all ingredients except for the peptide in three puffs of 1.33 IU per 2.24mg nostril.
OxytocinOxytocinOxytocin (OXT), a neuropeptide produced in the hypothalamus, is a key modulator of complex socioaffective responses including affiliation, social approach and attachment, stress and anxiety. Subjects receiving an intranasal spray of OXT (8 IU or 13.44 mg; Syntocinon-spray; Novartis, Switzerland) .
Primary Outcome Measures
NameTimeMethod
Functional network organization alterations in brain under resting state fMRI after drug administration70~85 minutes after drug administration

Using seed-based and network level functional connectivity analysis, as well as graph theory analysis , functional network organization in brain under eight minutes resting state will be detected and compared between oxytocin and placebo group.

Behavior,brain activities and representation patterns in the emotional judgement task after drug administration60~75 minutes after drug administration

Friend or Foe Task is used to measure the verbal versus nonverbal emotional judgement of subjects. Both the response of subjects and the brain activity are recorded in the task. How oxytocin influences the relationship between subjects' behavior and representation pattern of emotional judgement will be investigated through RSA(representation similarity analysis) of brain pattern.

Behavior, dynamics brain activities and networks in the model-based decision making task after drug administration35~60 minutes after drug administration

Two-Stage Decision Making Task is used to measure the model-based and model-free decision making process of subjects. The degree of model-based will be calculated by Computational modelling of Subjects' decision making process, and entering as modulation parameter in the OT effect on dynamic brain seed-based and network-based connectivity pattern.

Relationship of functional network organization in brain across resting state and task-based fMRI after drug administration60~85 minutes after drug administration

The functional brain activity in resting state, emotional judgement and decision making task will be compared. Both the functional segregation and integration will be measured using graph theory and network connectivity analysis to discover the OT effect on brain network organization across multiple cognitive states.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

School of Brain and Cognitive Sciences, Beijing Nornal University

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath